These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7590468)

  • 1. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
    Im DD; Duska LR; Rosenshein NB
    Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
    Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
    Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma in situ of the uterine cervix: management and outcome.
    Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
    Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
    Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
    Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
    Goldstein NS; Mani A
    Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocervical adenocarcinoma in situ. A histological entity to know].
    Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
    Schorge JO; Lea JS; Ashfaq R
    J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.